Martini Gregory S.
Kyverna Therapeutics, Inc. · Chief Financial Officer
Martini Gregory S. is listed in filings as Chief Financial Officer at Kyverna Therapeutics, Inc.. This profile follows SEC Form 4 activity through May 20, 2026, including sale activity. Recent filings connect the profile to Kyverna Therapeutics, Inc. (KYTX) and Ironwood Pharmaceuticals, Inc. (IRWD). The current snapshot covers public activity from Jan 29, 2025 to May 20, 2026. Reported amounts are shown as $2.8M to $40.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $40k10.5k shares | SellFeb 23, 2026 | $3.81 | $3.71 | |
| $1.1k1.3k shares | SellAug 11, 2025 | $0.84 | $3.71 | |
| $21k12.1k shares | SellFeb 10, 2025 | $1.76 | $3.71 |